{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:19:21Z","timestamp":1795029561408,"version":"4.10.2"},"reference-count":64,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/501100000654","name":"Marie Curie Cancer Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009795","name":"Pancreatic Cancer UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nordic Cancer Union"},{"DOI":"10.13039\/501100016982","name":"Rising Tide Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016982","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2017,12,13]]},"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:p>Cancer cachexia is a multifactorial syndrome characterised by an ongoing loss of skeletal muscle mass that cannot be fully reversed by conventional nutritional support alone. Cachexia has a high prevalence in cancer and a major impact on patient physical function, morbidity and mortality. Despite the consequences of cachexia, there is no licensed treatment for cachexia and no accepted standard of care. It has been argued that the multifactorial genesis of cachexia lends itself to therapeutic targeting through a multimodal treatment. Following a successful phase II trial, a phase III randomised controlled trial of a multimodal cachexia intervention is under way. Termed the MENAC trial (Multimodal\u2014Exercise, Nutrition and Anti-inflammatory medication for Cachexia), this intervention is based on evidence to date and consists of non-steroidal anti-inflammatory drugs and eicosapentaenoic acid to reduce inflammation, a physical exercise programme using resistance and aerobic training to increase anabolism, as well as dietary counselling and oral nutritional supplements to promote energy and protein balance. Herein we describe the development of this trial.<\/jats:p><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>NCT02330926.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjspcare-2017-001440","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T12:55:21Z","timestamp":1534424121000},"page":"258-265","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":161,"title":["Cancer cachexia: rationale for the MENAC (Multimodal\u2014Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial"],"prefix":"10.1136","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct01419145","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02330926","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Tora S","family":"Solheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J A","family":"Laird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trude R","family":"Balstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"Bye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guro","family":"Stene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie","family":"Baracos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Maddocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Fallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein","family":"Kaasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Fearon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,2,9]]},"reference":[{"key":"2024051613351971000_8.3.258.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70218-7"},{"key":"2024051613351971000_8.3.258.2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13539-011-0027-5","article-title":"The cachexia score (CASCO): a new tool for staging cachectic cancer patients","volume":"2","author":"Argil\u00e9s","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2024051613351971000_8.3.258.3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601781"},{"key":"2024051613351971000_8.3.258.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00558-6"},{"key":"2024051613351971000_8.3.258.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70055-X"},{"key":"2024051613351971000_8.3.258.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.02.033"},{"key":"2024051613351971000_8.3.258.7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jcsm.12201","article-title":"A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer","volume":"8","author":"Solheim","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2024051613351971000_8.3.258.8","first-page":"157","article-title":"Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative\/supportive care","volume":"5","author":"MacDonald","year":"2007","journal-title":"J Support Oncol"},{"key":"2024051613351971000_8.3.258.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.06.011"},{"key":"2024051613351971000_8.3.258.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.7742"},{"key":"2024051613351971000_8.3.258.11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.nut.2008.06.005","article-title":"NPY and brain monoamines in the pathogenesis of cancer anorexia","volume":"24","author":"Laviano","year":"2008","journal-title":"Nutrition"},{"key":"2024051613351971000_8.3.258.12","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2012.724536"},{"key":"2024051613351971000_8.3.258.13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690077"},{"key":"2024051613351971000_8.3.258.14","doi-asserted-by":"publisher","DOI":"10.1080\/01635580701365068"},{"key":"2024051613351971000_8.3.258.15","doi-asserted-by":"crossref","unstructured":"Macci\u00f2 A , Madeddu C , Gramignano G , et al . A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life. Gynecol Oncol 2012;124.doi:10.1016\/j.ygyno.2011.12.435","DOI":"10.1016\/j.ygyno.2011.12.435"},{"key":"2024051613351971000_8.3.258.16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/bjc.1997.463","article-title":"A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients","volume":"76","author":"McMillan","year":"1997","journal-title":"Br J Cancer"},{"key":"2024051613351971000_8.3.258.17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/bjc.1995.300","article-title":"Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients","volume":"72","author":"Wigmore","year":"1995","journal-title":"Br J Cancer"},{"key":"2024051613351971000_8.3.258.18","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-009-0016-x"},{"key":"2024051613351971000_8.3.258.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2014.08.010"},{"key":"2024051613351971000_8.3.258.20","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.391"},{"key":"2024051613351971000_8.3.258.21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25709"},{"key":"2024051613351971000_8.3.258.22","doi-asserted-by":"crossref","unstructured":"Ries A , Trottenberg P , Elsner F , et al . A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project. Palliat Med 2012;26.doi:10.1177\/0269216311418709","DOI":"10.1177\/0269216311418709"},{"key":"2024051613351971000_8.3.258.23","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25933"},{"key":"2024051613351971000_8.3.258.24","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21580"},{"key":"2024051613351971000_8.3.258.25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.clnu.2014.11.005","article-title":"Omega-3 supplements for patients in chemotherapy and\/or radiotherapy: A systematic review","volume":"34","author":"de Aguiar Pastore Silva","year":"2015","journal-title":"Clin Nutr"},{"key":"2024051613351971000_8.3.258.26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.nut.2014.12.002","article-title":"Eicosapentaenoic acid in cancer improves body composition and modulates metabolism","volume":"31","author":"Pappalardo","year":"2015","journal-title":"Nutrition"},{"key":"2024051613351971000_8.3.258.27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.5724"},{"key":"2024051613351971000_8.3.258.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2010.10.004"},{"key":"2024051613351971000_8.3.258.29","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2013.823239"},{"key":"2024051613351971000_8.3.258.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-003-0486-0"},{"key":"2024051613351971000_8.3.258.31","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2011.0098"},{"key":"2024051613351971000_8.3.258.32","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1332"},{"key":"2024051613351971000_8.3.258.33","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21013"},{"key":"2024051613351971000_8.3.258.34","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.10.1479"},{"key":"2024051613351971000_8.3.258.35","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00520-010-1011-x","article-title":"Nutritional status of patients with locally advanced pancreatic cancer: a pilot study","volume":"19","author":"Ferrucci","year":"2011","journal-title":"Support Care Cancer"},{"key":"2024051613351971000_8.3.258.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1514-8"},{"key":"2024051613351971000_8.3.258.37","first-page":"243","article-title":"Evaluation of nutritional status and dietary intake in patients with advanced cancer on palliative care","volume":"54","author":"Bovio","year":"2008","journal-title":"Minerva Gastroenterol Dietol"},{"key":"2024051613351971000_8.3.258.38","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830715)52:2<346::AID-CNCR2820520228>3.0.CO;2-Z"},{"key":"2024051613351971000_8.3.258.39","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1007\/s00520-012-1410-2","article-title":"Dietary energy density is associated with energy intake in palliative care cancer patients","volume":"20","author":"Wallengren","year":"2012","journal-title":"Support Care Cancer"},{"key":"2024051613351971000_8.3.258.40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.critrevonc.2014.02.005","article-title":"Dietary treatment of weight loss in patients with advanced cancer and cachexia: a systematic literature review","volume":"91","author":"Balstad","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"2024051613351971000_8.3.258.41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00508-005-0455-3","article-title":"Effects of a high-fat diet on body composition in cancer patients receiving chemotherapy: a randomized controlled study","volume":"117","author":"Breitkreutz","year":"2005","journal-title":"Wien Klin Wochenschr"},{"key":"2024051613351971000_8.3.258.42","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114510001315"},{"key":"2024051613351971000_8.3.258.43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1200\/JCO.1987.5.1.113","article-title":"A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer","volume":"5","author":"Evans","year":"1987","journal-title":"J Clin Oncol"},{"key":"2024051613351971000_8.3.258.44","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.91481.2008"},{"key":"2024051613351971000_8.3.258.45","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-009-0110-5"},{"key":"2024051613351971000_8.3.258.46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13539-012-0067-5","article-title":"Are there any benefits of exercise training in cancer cachexia?","volume":"3","author":"Argil\u00e9s","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2024051613351971000_8.3.258.47","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/SPC.0000000000000010","article-title":"Immunological and hormonal effects of exercise: implications for cancer cachexia","volume":"7","author":"Maddocks","year":"2013","journal-title":"Curr Opin Support Palliat Care"},{"key":"2024051613351971000_8.3.258.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2013.07.001"},{"key":"2024051613351971000_8.3.258.49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1590\/S1516-31802007000100005","article-title":"The effects of an individualized exercise intervention on body composition in breast cancer patients undergoing treatment","volume":"125","author":"Battaglini","year":"2007","journal-title":"Sao Paulo Med J"},{"key":"2024051613351971000_8.3.258.50","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.2024"},{"key":"2024051613351971000_8.3.258.51","doi-asserted-by":"crossref","unstructured":"Grande AJ , Silva V , Riera R , et al . Exercise for cancer cachexia in adults. Cochrane Database Syst Rev 2014:CD010804.doi:10.1002\/14651858.CD010804.pub2","DOI":"10.1002\/14651858.CD010804.pub2"},{"key":"2024051613351971000_8.3.258.52","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2010.529822"},{"key":"2024051613351971000_8.3.258.53","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0b013e3181e0c112"},{"key":"2024051613351971000_8.3.258.54","doi-asserted-by":"crossref","unstructured":"Awad S , Tan BH , Cui H , et al . Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr 2012;31.doi:10.1016\/j.clnu.2011.08.008","DOI":"10.1016\/j.clnu.2011.08.008"},{"key":"2024051613351971000_8.3.258.55","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.9730"},{"key":"2024051613351971000_8.3.258.56","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70146-8"},{"key":"2024051613351971000_8.3.258.57","doi-asserted-by":"publisher","DOI":"10.1002\/hed.20221"},{"key":"2024051613351971000_8.3.258.58","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0b013e328359b668"},{"key":"2024051613351971000_8.3.258.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2003.05.010"},{"key":"2024051613351971000_8.3.258.60","doi-asserted-by":"publisher","DOI":"10.1139\/H08-075"},{"key":"2024051613351971000_8.3.258.61","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"2024051613351971000_8.3.258.62","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-12-74"},{"key":"2024051613351971000_8.3.258.63","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr556"},{"key":"2024051613351971000_8.3.258.64","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jcsm.12167","article-title":"Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016","volume":"7","author":"von Haehling","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjspcare-2017-001440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T20:37:51Z","timestamp":1715891871000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/bmjspcare-2017-001440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,9]]},"references-count":64,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9,1]]},"published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1136\/bmjspcare-2017-001440"],"URL":"https:\/\/doi.org\/10.1136\/bmjspcare-2017-001440","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,9]]}}}